Ligand(LGND) - 2020 Q1 - Quarterly Report
Ligand(US:LGND)2020-05-08 20:28UNITED STATES SECURITIES AND EXCHANGE COMMISSION or ☐ Transition Report Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 For the Transition Period From ______ to ______ . Commission File Number: 001-33093 LIGAND PHARMACEUTICALS INCORPORATED Washington, D.C. 20549 ________________________________________________________________________________________ FORM 10-Q ________________________________________________________________________________________ ☒ Quarterly Report Pursuant to Section ...